Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dolby Laboratories (DLB) EBT Margin (2016 - 2025)

Historic EBT Margin for Dolby Laboratories (DLB) over the last 17 years, with Q4 2025 value amounting to 20.65%.

  • Dolby Laboratories' EBT Margin fell 34500.0% to 20.65% in Q4 2025 from the same period last year, while for Dec 2025 it was 21.59%, marking a year-over-year decrease of 25700.0%. This contributed to the annual value of 22.49% for FY2025, which is 20400.0% down from last year.
  • Per Dolby Laboratories' latest filing, its EBT Margin stood at 20.65% for Q4 2025, which was down 34500.0% from 13.57% recorded in Q3 2025.
  • In the past 5 years, Dolby Laboratories' EBT Margin registered a high of 33.4% during Q1 2024, and its lowest value of 3.11% during Q3 2023.
  • For the 5-year period, Dolby Laboratories' EBT Margin averaged around 20.31%, with its median value being 20.11% (2024).
  • Its EBT Margin has fluctuated over the past 5 years, first tumbled by -168200bps in 2021, then soared by 182100bps in 2023.
  • Over the past 5 years, Dolby Laboratories' EBT Margin (Quarter) stood at 26.0% in 2021, then rose by 15bps to 29.85% in 2022, then dropped by -14bps to 25.61% in 2023, then dropped by -6bps to 24.1% in 2024, then decreased by -14bps to 20.65% in 2025.
  • Its EBT Margin was 20.65% in Q4 2025, compared to 13.57% in Q3 2025 and 17.59% in Q2 2025.